Putting people with Fabry first: a talent that Amicus Therapeutics and FIN share. This commonality has ensured a strong partnership, spanning more than 16 years. Amicus Therapeutics is a pharma industry leader advancing the professional field of patient advocacy; it develops and delivers medicine for people living with rare diseases. Jayne C. Gershkowitz, Chief [...]
Fabry disease is rather easy to test for and diagnose, yet there continues to be limited awareness about the disease. Fabry Australia, a FIN member , is on a quest to place it on the national agenda. Sheridan Campbell explains how her organisation raises awareness. Challenges Oftentimes people exhibit symptoms for many years, without [...]
Save the Date Fabry Expert Meeting 2023 - April 21-23, 2023
Rare Diseases International Annual Membership Meeting
Fabry community leadership in an evolving landscape
International Fabry Congress MPS Lysosomales Association Spain
Help us to train Face2Gene to diagnose Fabry patients earlier!